A Contemporary Approach to Hypertensive Cardiomyopathy: Reversing Left Ventricular Hypertrophy

Purpose of Review To highlight pharmacological and non-pharmacological approaches to reversing hypertensive left ventricular hypertrophy (LVH). We identify high-risk phenotypes that may benefit from aggressive blood pressure (BP) management to prevent incident outcomes such as the development of ath...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Current hypertension reports 2020-10, Vol.22 (10), p.85-85, Article 85
Hauptverfasser:	Bourdillon, Maximillian T., Vasan, Ramachandran S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antihypertensive Agents - pharmacology Antihypertensive Agents - therapeutic use Antihypertensives Blood Pressure Cardiology Cardiomyopathies Cardiomyopathy Cardiovascular disease Diabetes Diuretics Electrocardiography Enzymes Epidemiology Family Medicine Female Gastrointestinal surgery General Practice Health care Heart Humans Hypertension Hypertension - complications Hypertension - drug therapy Hypertension and the Heart (B Upadhya Hypertrophy, Left Ventricular - complications Hypertrophy, Left Ventricular - drug therapy Internal Medicine Longitudinal studies Medicine Medicine & Public Health Metabolic Diseases Nephrology Primary Care Medicine Public health Section Editor Topical Collection on Hypertension and the Heart
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Purpose of Review To highlight pharmacological and non-pharmacological approaches to reversing hypertensive left ventricular hypertrophy (LVH). We identify high-risk phenotypes that may benefit from aggressive blood pressure (BP) management to prevent incident outcomes such as the development of atherosclerotic cardiovascular disease, stroke, and heart failure. Recent Findings LVH is a modifiable risk factor. Intensive BP lowering (systolic BP
ISSN:	1522-6417 1534-3111
DOI:	10.1007/s11906-020-01092-8